Lanean...
Risk of Suicidal Events With Atomoxetine Compared to Stimulant Treatment: A Cohort Study
BACKGROUND: Antidepressant effects on increased suicidality in children have raised public concern in recent years. Approved in 2002 for attention-deficit/hyperactivity disorder treatment, the selective noradrenalin-reuptake-inhibitor atomoxetine was initially investigated for the treatment of depre...
Gorde:
| Argitaratua izan da: | Pediatrics |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Academy of Pediatrics
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4845870/ https://ncbi.nlm.nih.gov/pubmed/27244795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2015-3199 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|